DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Alocril (Nedocromil Sodium Ophthalmic) - Published Studies

 
 



Alocril Related Published Studies

Well-designed clinical trials related to Alocril (Nedocromil Ophthalmic)

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. [2009.05]

AMP challenge induces a decrease in FE(NO) in asthmatic subjects modulated by nedocromil. [2006.12]

Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. [2006.05]

Dissociation in the effect of nedocromil on mannitol-induced cough or bronchoconstriction in asthmatic subjects. [2005.09]

Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study. [2004.08]

A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. [2003.07]

Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis. [2003.06]

Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. [2003.06]

Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: a comparative study. [2003.01]

Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis. [2002.07]

[Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children] [2002.03]

[The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children] [2002.02]

Allergen challenge and deposition of nedocromil sodium in asthma. [2002.01]

Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. [2001.09]

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. [2001.09]

Double-blind, randomized, placebo-controlled trial of effect of nedocromil sodium on clinical and inflammatory parameters of asthma in children allergic to dust mite. [2001.06]

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model. [2000.12]

Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis. [2000.09]

Nedocromil sodium in the treatment of exercise-induced asthma: a meta-analysis. [2000.07]

Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. [2000.06]

Nedocromil and exercise-induced asthma: acute and chronic effects. [1999.10]

Comparison of two different dose regimens of nedocromil sodium with placebo in the management of childhood asthma. [1999.09]

Regular albuterol or nedocromil sodium--effects on airway subepithelial tenascin in asthma. [1999.07]

Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis. [1999.04]

Early use of inhaled nedocromil sodium in children following an acute episode of asthma. [1999.04]

Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. [1999.02]

Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe. [1998.09]

Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion. [1998.08]

Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma. [1998.06]

Effect of nedocromil sodium on bronchial hyperreactivity in children with nonatopic asthma. [1997.12]

Nedocromil sodium in obstructive airways disease: effect on symptoms and plasma protein leakage in sputum. [1997.07]

Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. [1997.04]

Inhibition of histamine release by nedocromil sodium reduces exercise-induced hypoxemia in master athletes. [1997.01]

[The effect of nedocromil sodium on spontaneous production of histamine releasing factor (HRF) by mononuclear blood cells in patients with nonatopic bronchial asthma] [1997]

Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen. [1996.12]

Effect of regular nedocromil sodium or albuterol on bronchial inflammation in chronic asthma. [1996.11]

Inhaled nedocromil sodium in symptomatic young children born prematurely. [1996.09]

Compliance with nedocromil sodium and a nedocromil sodium/salbutamol combination. Compliance Working Group. [1996.05]

A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment? [1996.04]

Effects of nedocromil sodium in steroid-resistant asthma: a randomized controlled trial. [1996.02]

Equivalence of pharmacokinetic characteristics and bronchodilating effect between two combined formulations of nedocromil sodium and salbutamol: MDI and nebulizer solution. [1996]

The effect of nedocromil sodium on childhood asthma during the viral season. [1995.12]

Effect of inhaled nedocromil sodium therapy on blood gas changes in children challenged with ultrasonically nebulized distilled water. A comparison of 8 mg versus 16 mg daily dose. [1995.10]

Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. [1995.10]

Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease. [1995.06]

Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. [1995.06]

The use of twice daily nedocromil sodium in the treatment of asthma. [1995.04]

Effect of nedocromil sodium on exercise-induced bronchoconstriction exacerbated by inhalation of cold air. [1995.04]

Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. [1995.02]

Treatment of nocturnal asthma with nedocromil sodium. [1994.12]

Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease. [1994.10]

Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children. [1994.10]

A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. [1994.09]

Nedocromil sodium 2% eye drops for twice-daily treatment of seasonal allergic conjunctivitis: a Swedish multicentre placebo-controlled study in children allergic to birch pollen. [1994.09]

The preventive effect of nedocromil or furosemide alone or in combination on exercise-induced asthma in children. [1994.08]

High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma. [1994.08]

Evaluation of nedocromil sodium 2% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. [1994.07]

Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children. [1994.05]

A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis. [1994.05]

The effect of physiological manoeuvres on the absorption of inhaled nedocromil sodium. [1994.03]

Effects of nedocromil sodium on bronchospasm and HS-NCA release induced by allergen inhalation in asthmatic patients. [1994.03]

Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. [1994.01]

Nedocromil sodium versus albuterol in the management of allergic asthma. [1994.01]

Group comparative trial of 2% nedocromil sodium with placebo in the treatment of seasonal allergic conjunctivitis. [1994.01]

[Inhaled corticotherapy sparing effect by sodium nedocromil in moderate to severe asthma] [1994]

Effect of multiple doses of nedocromil sodium given after allergen inhalation in asthma. [1993.12]

Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. [1993.10]

Nedocromil sodium vs. sodium cromoglycate pressurized aerosol in the prevention of bronchoconstriction induced by ultrasonic nebulized distilled water in asthmatic children. [1993.10]

Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo. [1993.09]

Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease. [1993.08]

Effects of nedocromil sodium on the bronchomotor response to sulfur dioxide in asthmatic patients. [1993.07]

Inhibition of the late asthmatic response by nedocromil sodium administered more than two hours after allergen challenge. [1993.07]

Nedocromil sodium in the prevention of exercise-induced bronchospasm in athletes with asthma. [1993.06]

Albuterol and nedocromil sodium affect airway and leukocyte responses to allergen. [1993.06]

Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids. [1993.05]

Nedocromil sodium is rapidly effective in the therapy of seasonal allergic rhinitis. [1993.05]

Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. [1993.04]

[Modification of nonspecific bronchial hyperreactivity to cold air hyperventilation and carbachol by nedocromil and budesonide] [1993.03]

[Nedocromil in treating chronic bronchial asthma of a moderate course] [1993.02.15]

Double blind, placebo controlled study of nedocromil sodium in asthma. [1993.02]

Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis. A multicentre double blind clinical trial. [1993.02]

Effect of inhaled disodium cromoglycate and nedocromil sodium on propranolol-induced bronchoconstriction. [1993.02]

The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. [1993.01]

Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease. [1993.01]

The effect of nedocromil sodium on histamine responsiveness in clinically stable asthmatic children. [1993]

Protective effect of nedocromil sodium on the dual asthmatic response to bronchial antigen challenge. [1993]

Nedocromil sodium in contact-lens-associated papillary conjunctivitis. [1993]

Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma. [1992.11]

Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium. [1992.11]

Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis. [1992.10]

Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. [1992.10]

Dose duration of nebulized nedocromil sodium in exercise-induced asthma. [1992.09]

Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma. [1992.07]

Nedocromil sodium inhibits the increase in airway reactivity induced by platelet activating factor in humans. [1992.07]

The long-term effect of nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects. [1992.05]

Nedocromil sodium inhibits the early and late asthmatic response to exercise. [1992.04]

Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. [1992.03]

Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma. [1992.02]

Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis. [1992.01.15]

Protection of nedocromil sodium on bronchoconstriction induced by inhaled neurokinin A (NKA) in asthmatic patients. [1992.01]

Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. [1992]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012